Humanity’s most critical pillars, food and medicine, require recombinant proteins - key signalling molecules. Existing manufacturing systems for recombinant proteins are incapable of making upwards of 50% of newly identified proteins, creating a massive bottleneck in these key industries. At Future Fields, we’re solving this problem by reinventing biomanufacturing with a world's first multicellular production platform. With our EntoEngine platform, we unlock production of the most complex proteins at low cost and massive scale.